We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Kromek Group Plc | LSE:KMK | London | Ordinary Share | GB00BD7V5D43 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.10 | -1.59% | 6.20 | 6.00 | 6.40 | 6.30 | 6.20 | 6.30 | 1,368,701 | 16:29:40 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Miscellaneous Metal Ores,nec | 17.31M | -6.1M | -0.0102 | -6.08 | 37.22M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/3/2021 13:33 | 33 mick- what is your comment and relevance to kmk please- good or bad? | ali47fish | |
29/3/2021 11:51 | Maybe this is where Simon Thompson s False positive 1/800,000 figure came from.. Just saw this on Oxfords site. "Oxford Nanopore has driven continuous improvement in accuracy of its sequencing platform since launch, through combining new sequencing chemistries with continuously evolving data analysis algorithms. In addition to high single-pass accuracy, the nanopore platform is now able to deliver single molecule consensus accuracy of 99.995% with UMIs, and̷ All Oxfords Sequencing platforms are under constant improvement s and updates, world leading UK technology. | 33mick | |
29/3/2021 10:48 | Same for BATM, (another Simon Thompson tip I bought) despite them being a company developing a myriad of solutions to the pandemic, there was a delay in the share price reacting. But when it did it tripled in 3months. | aqc888 | |
29/3/2021 07:03 | The companies aren’t comparable. But the scenario is. I was questioning to myself why the market wasn’t excited by this device and looked at Moderna to see if the market was excited by the most promising vaccine for the pandemic at the start. To my surprise Moderna s share price took a month after the pandemic was declared to start rising. Dispite it being reported all over the media that it was a front runner in producing a vaccine. Hope the same is true for Kromek! | aqc888 | |
28/3/2021 22:51 | pinkfoot2- both have peel and contain vitamin C. So in that respect, I wouldn't say that they're "not comparable whatsoever". Similarly for the aforementioned post... DM | dougmachin | |
28/3/2021 22:48 | AQC888 - more great posts, agreed, could cause havoc at airports, needs real careful thought about how to implement. Hence, why this is taking time. Also, it's easy for governments to spend hours and billions arguing over Brexit or which vaccine to buy (the issues are right there and the public are demanding action), but for someone to think about issues like nuclear or pathogen detection... I imagine that takes a whole lot of careful thought. You'd have to go and find all the issues, structure them, write them in a paper, convince committees which product to buy, again all massively time consuming. I know this is not a certainty, but if it was, then they'd be no reward. When everyone's scrambling at 30p to get in, the boat's already sailed. DM | dougmachin | |
28/3/2021 22:11 | You’re right mate-not comparable whatsoever.A bit like comparing an orange with a banana | pinkfoot2 | |
28/3/2021 21:02 | Just been looking at the Moderna share price to see how the market reacted to the most promising vaccine company at the beginning of the pandemic and it was pretty slow. Not comparable to Kromek I know, but I make the comparison as it’s a company that similarly was creating a solution to an unknown unresearched situation. Like Kromek. Moderna share price in the year pre pandemic 12-27c. Date pandemic officially declared 21.3c. 1month into pandemic 33c, 2months into pandemic 66c, upto a peak of 148c last month. | aqc888 | |
28/3/2021 20:37 | I’m still hanging on to Kromek though despite my worries. It appears to be a good company with a few ‘strong buy’ recommendations from Simon Thompson. Last ‘strong buy’ I followed ST on was sylvanian platinum which surged big time. This alluring wild card of the biological pathogen detector that’s thrown in for free within the Kromek share price makes this share a speculative buy backed up by a fairly solid company that continually has had bad luck in my opinion. I just can’t quite understand why they haven’t sold these in advanced to airlines & airports. Imagine sitting at the gate waiting to board your plane and one of these machines is monitoring the air so every flight is ‘covid secure’ like an extra security measure. You’d think such a device before boarding every plane destined for the UK would make the risk of mutant strains entering the uk far far lower. 1/800,000 as Simon Thompson reported. Perhaps Kromek don’t want to step on the toes of OEM suppliers to airports (who are their clients) or perhaps airlines don’t want the havoc positive covid tests would case to their schedules. If a positive covid case was detected by the machine at the boarding gate, the airline wouldn’t know who was positive and they might be liable to getting sued if they didn’t cancel the flight. So they might not want these devices as the cost of alerts could be huge. All pure speculation, but if this type of machine (and the Kromek one seems to be the market leader) becomes an essential piece of kit in just one these settings (hospitals, care homes, gp surgeries, schools, shopping malls, offices, airports) the Kromek share price will go absolutely nuts and blow away analyst Paul Hills global market estimate of £500m. Remember they have been scaling up their production capabilities lately so could be well placed to manufacture (as well as license their invention to other manufacturers) and exploit the market to huge gains. I’m holding on and think I just persuaded myself to top up my holding! | aqc888 | |
28/3/2021 19:38 | I’m afraid Kromek haven’t commercialised anything mate | pinkfoot2 | |
28/3/2021 10:40 | AQC888, two very good post’s there. Echo my thoughts entirely. | b00mb0y | |
28/3/2021 06:34 | the government had to spend money on ventilators. anybody know how many ventilators have been sold/manufactured by Kromek who was/is apparently manufacturing them in the UK under licence from Metran? ALL IMO. DYOR. QP | quepassa | |
27/3/2021 23:50 | The difference is the government had to spend money on vaccines and track and trace. That decision was made for them, no choice, had to do it. For Kromek's products, that's a different thing... it's a choice. | dougmachin | |
27/3/2021 14:30 | Simon Thompson reported in early January that Kromek had a machine to detect covid that gave a false alert in only 1/800,000 tests. Which sounds on the surface a fantastically remarkable tool in the fight against the pandemic, then he later states the UK government gave a grant of just £1.25m to help develop it. I would think if I were in government spending billions on pcr tests and tens of billions on track and trace projects that a company with biological pathogen detector which has such accuracy would be given whatever they wanted to develop their machine ASAP. I wouldn’t give them just £1.25m and hang around for months for them to put the finishing touches on it. This machine should have an incredibly important role to play in opening up of global air links, schools, shopping malls etc. Not only for this pandemic, but for insurance against future pandemics. Yet it’s totally unreported about anywhere. I really just don’t understand. Either we’re sitting on an incredible bargain here or people aren’t interested in this device for a reason. | aqc888 | |
27/3/2021 13:22 | Kromek Group is mentioned a couple of times I seem to recall. | davethechef | |
27/3/2021 13:20 | Yep that's the twitter MP link I was trying to post yesterday but wouldn't allow. But ofcourse one can copy & paste sections as you' ve done 33mick. Ta. I'd say encouraging & all publicity helps | davethechef | |
27/3/2021 13:12 | Kromek Group plc @kromekgroup · Mar 26 Our local MP Paul Howell was speaking in Parliament on Tuesday (23rd March) on the subject of ARIA, mentioning Kromek in relation to raising his belief See Paul's speech here - [...] | dougmachin | |
27/3/2021 12:41 | This should encourage you AQ888, that a 20 strong bio team are working to get the first Patho detection unit configured for field trails soon... Kromek have indication from March onwards.. MP Paul Howell was speaking in Parliament on Tuesday (23rd March) on the subject of ARIA, UK's proposed Advanced Research institution similar to DARPA. "The company has created a whole biotech part of the business, and because of this funding, this part of the business has already created 20 high-paid jobs and intellectual property in the space; it has real leverage potential." Full text on kmk's twitter | 33mick | |
27/3/2021 10:33 | You got some valid points,there's always risk they don't take of in the numbers to bring substantial profits; but I personally believe they will in the not too distant future. A certain reasonable market capital & subsequent share price has to be reflected by their cash reserves & success of all there other products though without the unlikely event the much anticipated pathogen/ covid detectors don't sell in the impressive numbers. And I believe we are at this point in the share point & I continue to accumulate. I may be proved wrong but that's the risk I' ve accepted! | davethechef | |
27/3/2021 07:09 | Very confused by Kromek, they seem to have developed what should be one of the best scientific devices to fight the pandemic, yet it is almost completely ignored by a the media which is mainly focused on reporting the pandemic. Similar sized companies such as BATM have developed and brought to market covid products and have seen their share price triple. I’m worried this biological pathogen detector sounds too good to be true. I’m hoping that Kromek is a company of brilliant scientists who are so focused on the science they have forgotten about the business side. Governments were buying vaccines before they were developed or tested and I would have thought governments would be ordering thousands of these machines on the off chance that they might actually work, but nobody seems interested. Which makes me slightly worried... | aqc888 | |
26/3/2021 15:34 | From Kromek Group's twitter [...] | davethechef | |
26/3/2021 15:21 | Just seen this from few weeks ago | 33mick | |
26/3/2021 12:13 | We have staff that can't get a visa issued to South Korea from the UK, doing all their work via Zoom calls. Been waiting for some staff for some time now. South Korea very concerned about the strain of virus from the UK. My point is the tentacles of Covid are still running deep, might not be worth to give up on the 13million just yet. Difficult to get a visa, let alone 13million worth of stock delivered. DM | dougmachin |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions